Upset that your calls continue to prove incorrect?
- Forums
- ASX - By Stock
- NEU
- Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.1%
!
$13.81

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m, page-32
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.81 |
Change
1.270(10.1%) |
Mkt cap ! $1.729B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $12.76M | 929.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 743 | $13.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.81 | 285 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 253 | 13.820 |
3 | 716 | 13.810 |
2 | 416 | 13.800 |
5 | 1309 | 13.790 |
4 | 1316 | 13.780 |
Price($) | Vol. | No. |
---|---|---|
13.830 | 1 | 1 |
13.840 | 788 | 10 |
13.850 | 1423 | 4 |
13.860 | 1392 | 6 |
13.870 | 1291 | 4 |
Last trade - 14.28pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online